Enhanced cardiac angiotensinogen gene expression and angiotensin converting enzyme activity in tachypacing-induced heart failure in rats

Basic Res Cardiol. 1991 Jul-Aug;86(4):303-16. doi: 10.1007/BF02191528.

Abstract

The aim of the study was to analyze changes in myocardial angiotensinogen gene expression and myocardial angiotensin converting enzyme activity in slowly progressing low-output failure. In adult, male Wistar rats, acute ventricular tachypacing by 610 to 620 impulses per minute lowered end-diastolic external diameter of the left ventricle by 2.6% (p less than 0.01), but did not lower cardiac output or abolish coronary reserve, since left-ventricular subendocardial blood flow of paced rats increased under dipyridamole (2 mg/kg i.v.) by 56% (p less than 0.01). Systemic neuroendocrine activation and ventricular dilation without enlargement of ventricular mass developed subsequent to chronic tachypacing, but left-ventricular diameter during pacing never exceeded the value of sham rats on sinus rhythm. After 2 weeks, cardiac output was lowered by 14% (p less than 0.001), cardiopulmonary blood volume was elevated by 30% (p less than 0.001), and angiotensinogen mRNA and angiotensin converting enzyme activity in ventricular myocardium were doubled. We conclude that conditions for an enhanced intracardiac angiotensin II-formation developed in tachypacing-induced heart failure, but that enhanced systolic wall stress or myocardial ischemia are not required for this activation of the local cardiac renin-angiotensin system.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensinogen / biosynthesis*
  • Angiotensinogen / genetics
  • Animals
  • Cardiac Output, Low / metabolism*
  • Cardiac Pacing, Artificial
  • Gene Expression Regulation
  • Hemodynamics
  • Male
  • Peptidyl-Dipeptidase A / metabolism*
  • RNA, Messenger / analysis
  • Rats
  • Rats, Inbred Strains

Substances

  • RNA, Messenger
  • Angiotensinogen
  • Peptidyl-Dipeptidase A